Corcept Therapeutics Incorporat (CORT) Financials

CORT Assets vs Liabilities

DateAssetsLiabilities
2024-03-31 655.9 million 108.1 million
2023-12-31 621.5 million 114.8 million
2023-09-30 594.0 million 132.3 million
2023-06-30 524.6 million 103.0 million

CORT Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-03-31 23.8 million 13.2 million
2023-12-31 5.9 million 13.1 million
2023-09-30 52.9 million 12.9 million
2023-06-30 42.2 million 11.9 million

CORT Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2024-03-31 27.5 million
2023-12-31 31.4 million
2023-09-30 31.4 million
2023-06-30 27.5 million

CORT Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-03-31 410.8 million - 76000
2023-12-31 368.2 million - 151000
2023-09-30 355.2 million - 225000
2023-06-30 363.3 million - 297000

CORT Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-03-31 109.9 million
2023-12-31 110.9 million
2023-09-30 111.1 million
2023-06-30 109.6 million

CORT Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-03-31 - 58.5 million 56.3 million -
2023-12-31 - 54.7 million 47.2 million -
2023-09-30 37000 45.5 million 45.3 million -
2023-06-30 102000 43.3 million 43.3 million -

CORT Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-03-31 146.8 million 2.5 million
2023-12-31 135.4 million 1.9 million
2023-09-30 123.6 million 1.6 million
2023-06-30 117.7 million 1.6 million

CORT

Price: $30.17

52 week price:
20.84
34.28

Payout Ratio Range:
115.38%
200.00%

Earnings Per Share: 1.05 USD

P/E Ratio: 28.76

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 611800

Ebitda: 13.7 million

Market Capitalization: 2.5 billion

Links: